LACTATE DEHYDROGENASE (LDH) - ANVISA Registration 10347320258

Access comprehensive regulatory information for LACTATE DEHYDROGENASE (LDH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10347320258 and manufactured by HORIBA ABX SAS. The registration is held by HORIBA INSTRUMENTS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10347320258
Registration Details
ANVISA Registration Number: 10347320258
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

ABX Pentra LDH IFCC CP
Risk Class II

Registration Details

10347320258

25351266376201031

01759236000179

Company Information

HORIBA ABX SAS
France
PT: FRANÇA

Dates and Status

Jun 23, 2010

VIGENTE

09/18/2025 19:00:01